Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinoma

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecular Carcinogenesis

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mc.20382PMID 17849424
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic clonal diversity predicts progression to esophageal adenocarcinoma

  2006cited by this paper
• TP53 Gene Mutations Are Rare in Nondysplastic Barrett's Esophagus

  2006cited by this paper
• Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma.

  2006cited by this paper
• Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma.

  2006cited by this paper
• Esophagitis: Incidence and Risk of Esophageal Adenocarcinoma—A Population-Based Cohort Study

  2006cited by this paper
• P53, COX-2, iNOS Protein Expression Changes and Their Relationship with Anti-Oxidant Enzymes in Surgically and Multi-Modality Treated Esophageal Carcinoma Patients

  2006cited by this paper
• Body Mass Index and Adenocarcinomas of the Esophagus or Gastric Cardia: A Systematic Review and Meta-analysis

  2006cited by this paper
• 8-Nitroguanine, a Product of Nitrative DNA Damage Caused by Reactive Nitrogen Species: Formation, Occurrence, and Implications in Inflammation and Carcinogenesis

  2006cited by this paper
• Tumors face NO problems?

  2006cited by this paper
• Controlling tumor growth by modulating endogenous production of reactive oxygen species.

  2005cited by this paper
• Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?

  2005cited by this paper
• Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma.

  2005cited by this paper
• The antioxidant function of the p53 tumor suppressor

  2005cited by this paper
• The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress.

  2005cited by this paper
• Nitric oxide induces oral squamous cell carcinoma cells apoptosis with p53 accumulation.

  2005cited by this paper
• Human pancreatic exocrine response to nutrients in health and disease

  2005cited by this paper
• Differential requirement of signal pathways for benzo[a]pyrene (B[a]P)-induced nitric oxide synthase (iNOS) in rat esophageal epithelial cells.

  2005cited by this paper
• Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma

  2005cited by this paper
• Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting.

  2005cited by this paper
• Nitric oxide-induced apoptosis in lymphoblastoid and fibroblast cells dependent on the phosphorylation and activation of p53.

  2005cited by this paper
• Accumulation of 8-nitroguanine in human gastric epithelium induced by Helicobacter pylori infection.

  2004cited by this paper
• Chemopreventive Effects of a Selective Nitric Oxide Synthase Inhibitor on Carcinogen-Induced Rat Esophageal Tumorigenesis

  2004cited by this paper
• Nitric oxide and p53 in cancer‐prone chronic inflammation and oxyradical overload disease

  2004cited by this paper
• Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis.

  2004cited by this paper
• Biomarkers of Esophageal Adenocarcinoma and Barrett’s Esophagus

  2004cited by this paper
• Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle

  2004cited by this paper
• Nitric Oxide and Ionizing Radiation Synergistically Promote Apoptosis and Growth Inhibition of Cancer by Activating p53

  2004cited by this paper
• Inducible nitric oxide synthase expression in N‐nitrosomethylbenzylamine (NMBA)‐induced rat esophageal tumorigenesis

  2004cited by this paper
• Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.

  2004cited by this paper
• Nitric oxide, oxidants, and protein tyrosine nitration

  2004cited by this paper
• Review article: oesophago‐gastric adenocarcinoma — an epidemiological perspective

  2004cited by this paper
• Role of p53 in Sensing Oxidative DNA Damage in Response to Reactive Oxygen Species-Generating Agents

  2004cited by this paper
• Nitric oxide evoked p53-accumulation and apoptosis.

  2003cited by this paper
• Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.

  2003cited by this paper
• Nitric oxide induces phosphorylation of p53 and impairs nuclear export

  2003cited by this paper
• Reflux, Barrett's oesophagus and adenocarcinoma: burning questions

  2003cited by this paper
• Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells.

  2003cited by this paper
• 8-nitroguanine formation in the liver of hamsters infected with Opisthorchis viverrini.

  2003cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Clinical practice. Barrett's Esophagus.

  2002cited by this paper
• Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype.

  2002cited by this paper
• Inflammatory gradient in Barrett’s oesophagus: implications for disease complications

  2002cited by this paper
• Role of molecular biology in the follow-up of patients who have Barrett's esophagus.

  2002cited by this paper
• Association between Inducible Nitric Oxide Synthase Expression and p53 Status in Human Esophageal Squamous Cell Carcinoma

  2002cited by this paper
• The role of nitric oxide in cancer

  2002cited by this paper
• ROS, stress‐activated kinases and stress signaling in cancer

  2002cited by this paper
• Nitric oxide synthase 2 mRNA expression in relation to p53 and adenomatous polyposis coli mutations in primary colorectal adenocarcinomas.

  2002cited by this paper
• Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.

  2002cited by this paper
• Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran

  2002cited by this paper
• Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran

  2001cited by this paper
• p53 Gene Mutation and Protein Accumulation during Neoplastic Progression in Barrett's Esophagus

  2001cited by this paper
• Nutrient intake and risk of subtypes of esophageal and gastric cancer.

  2001cited by this paper
• A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States)

  2001cited by this paper
• Evidence for peroxynitrite-mediated modifications to p53 in human gliomas: possible functional consequences.

  2001cited by this paper
• The mechanisms for nitration and nitrotyrosine formation in vitro and in vivo: Impact of diet

  2001cited by this paper
• The contribution of endogenous sources of DNA damage to the multiple mutations in cancer.

  2001cited by this paper
• New issues about nitric oxide and its effects on the gastrointestinal tract.

  2001influential reference
• Peroxynitrite-induced DNA damage in the supF gene: correlation with the mutational spectrum.

  2000cited by this paper
• Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease.

  2000cited by this paper
• Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens.

  2000cited by this paper
• Nitric oxide and intestinal inflammation.

  2000cited by this paper
• Nitrotyrosine in esophageal squamous cell carcinoma and relevance to p53 expression.

  2000cited by this paper
• Association between Body Mass and Adenocarcinoma of the Esophagus and Gastric Cardia

  1999cited by this paper
• Increased expression of inducible nitric oxide synthase and peroxynitrite in Helicobacter pylori gastric ulcer.

  1999cited by this paper
• Frequent expression of inducible nitric oxide synthase in esophageal squamous cell carcinomas.

  1999cited by this paper
• The chemistry of DNA damage from nitric oxide and peroxynitrite.

  1999cited by this paper
• Peroxynitrite: an endogenous oxidizing and nitrating agent

  1999cited by this paper
• Association of increased immunostaining for inducible nitric oxide synthase and nitrotyrosine with fibroblast growth factor transformation in pancreatic cancer.

  1999cited by this paper
• Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

  1999cited by this paper
• DNA damage in deoxynucleosides and oligonucleotides treated with peroxynitrite.

  1999cited by this paper
• p53-mutant clones and field effects in Barrett's esophagus.

  1999cited by this paper
• Immunohistochemical methods to detect nitrotyrosine.

  1999cited by this paper
• Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer.

  1999cited by this paper
• Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas.

  1998cited by this paper
• Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide.

  1998cited by this paper
• Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease

  1998cited by this paper
• Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia.

  1998cited by this paper
• Cytotoxicity of Peroxynitrite in Rat Pancreatic Acinar AR4–2J Cells

  1997cited by this paper
• Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease.

  1996cited by this paper
• Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases.

  1996cited by this paper
• Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53.

  1996cited by this paper
• Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells.

  1996cited by this paper
• Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma.

  1995cited by this paper
• Adenocarcinoma of the esophagus: role of obesity and diet.

  1995cited by this paper
• Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer.

  1993cited by this paper
• p53 gene mutations in Barrett's epithelium and esophageal cancer.

  1991cited by this paper
• Dietary factors and the incidence of cancer of the stomach.

  1985cited by this paper
• [Inflammation and cancer].

  1974cited by this paper

• Role of Lactobacillus Johnsonii in Gastroesophageal Reflux Disease in Obese Mice Following Sleeve Gastrectomy

  2025cites this paper
• Unveiling the significance of inducible nitric oxide synthase: its impact on cancer progression and clinical implications.

  2024cites this paper
• Carcinogen 4-Nitroquinoline Oxide (4-NQO) Induces Oncostatin-M (OSM) in Esophageal Cells

  2023cites this paper
• Recognizing Pattern and Rule of Mutation Signatures Corresponding to Cancer Types

  2021cites this paper
• Non-surgical animal model of gastroesophageal reflux disease by overeating induced in mice

  2021cites this paper
• DNA Methylation—a Potential Source of Mitochondria DNA Base Mismatch in the Development of Diabetic Retinopathy

  2018cites this paper
• Evaluating the Correlation Between the Survival Rate of Patients with Esophageal Squamous Cell Carcinoma and Expression of p53 and Cyclin D1 Biomarkers Along with Other Prognostic Factors

  2018cites this paper
• Support for involvement of the renin–angiotensin system in dysplastic Barrett’s esophagus

  2017cites this paper
• Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett’s esophagus, and high-grade dysplasia/esophageal adenocarcinoma

  2017cites this paper
• Oesophageal cancer

  2017cites this paper
• 2 Gastroesophageal Reflux Disease : Molecular Predictors in Neoplastic Progression of Barrett ’ s Esophagus

  2017cites this paper
• Role of nitric oxide in the pathogenesis of Barrett's-associated carcinogenesis.

  2016cites this paper
• 8-Oxo-7,8-dihydro-2′-deoxyguanosine and other lesions along the coding strand of the exon 5 of the tumour suppressor gene P53 in a breast cancer case-control study

  2016cites this paper
• Nitric Oxide and Genomic Stability

  2015cites this paper
• Barrett’s Esophagus and Cancer Risk: How Research Advances Can Impact Clinical Practice

  2014cites this paper
• TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix

  2014cites this paper
• Alterations in TP53 gene – Implications in Tumorigenesis Process and Prognosis in Central Nervous System Cancer

  2014cites this paper
• Involvement of luminal nitric oxide in the pathogenesis of the gastroesophageal reflux disease spectrum

  2014cites this paper
• Molecular Pathology of Barrett’s Metaplasia and Esophageal Adenocarcinoma

  2013cites this paper
• p53 in the Clinics

  2013cites this paper
• Household Income Is Associated with the p53 Mutation Frequency in Human Breast Tumors

  2013cites this paper
• TP53: Coordinator of the Processes That Underlie the Hallmarks of Cancer

  2013cites this paper
• Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review.

  2013cites this paper
• Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.

  2013cites this paper
• Gastroesophageal Reflux Disease: Molecular Predictors in Neoplastic Progression of Barrett's Esophagus

  2012cites this paper
• The role of nitric oxide in the induction of caudal-type homeobox 2 through epidermal growth factor receptor in the development of Barrett's esophagus

  2012influential citation
• Emerging avenues linking inflammation and cancer.

  2012cites this paper
• Inducible nitric oxide synthase (iNOS) and nitric oxide (NO) are important mediators of reflux-induced cell signalling in esophageal cells.

  2012cites this paper
• Different mutation profiles associated to P53 accumulation in colorectal cancer.

  2012cites this paper
• TP53 mutations, human papilloma virus DNA and inflammation markers in esophageal squamous cell carcinoma from the Rift Valley, a high-incidence area in Kenya

  2011cites this paper
• Dietary freeze-dried black raspberry's effect on cellular antioxidant status during reflux-induced esophagitis in rats.

  2011cites this paper
• Whole Genome Expression Array Profiling Highlights Differences in Mucosal Defense Genes in Barrett's Esophagus and Esophageal Adenocarcinoma

  2011cites this paper
• Oesophageal cancer

  2011cites this paper
• Identificación y análisis del efecto de mutaciones TP53 asociadas a la patología tumoral

  2011cites this paper
• The Na+/H+ Exchanger Controls Deoxycholic Acid-Induced Apoptosis by a H+-Activated, Na+-Dependent Ionic Shift in Esophageal Cells

  2011cites this paper
• Dietary folate and vitamin B6 are not associated with p53 mutations in esophageal adenocarcinoma

  2010cites this paper
• TP53 mutations in human cancers: origins, consequences, and clinical use.

  2010cites this paper
• Obesity is not associated with adverse outcome following surgical resection of oesophageal adenocarcinoma.

  2010cites this paper
• A novel mechanism of acid and bile acid-induced DNA damage involving Na+/H+ exchanger: implication for Barrett's oesophagus

  2010influential citation
• Nitric Oxide and Cancer

  2010cites this paper
• Nitric oxide-mediated invasion in Barrett's high-grade dysplasia and adenocarcinoma.

  2010cites this paper
• Prognostic value of p53 mutations in oesophageal adenocarcinoma: final results of a 15-year prospective study.

  2010cites this paper
• Nitric oxide‐mediated inhibition of NFκB regulates hyperthermia‐induced apoptosis

  2009cites this paper
• Barrett’s oesophagus: an ideal model to study cancer genetics

  2009cites this paper
• Sodium deoxycholate causes nitric oxide mediated DNA damage in oesophageal cells

  2009cites this paper
• Untersuchungen zur Ätiologie des ösophagealen Adenokarzinoms in Abhängigkeit zur Myosminbelastung durch die Ernährung

  2009cites this paper
• Physical activity, obesity and risk for esophageal adenocarcinoma.

  2009cites this paper
• HIF-1alpha protein expression is associated with the environmental inflammatory reaction in Barrett's metaplasia.

  2009cites this paper
• Shining light on Barrett’s esophagus

  2009cites this paper
• Regulation of CDX2 expression in esophageal adenocarcinoma

  2009cites this paper
• Immunohistochemical analysis of selected molecular markers in esophagus precancerous, adenocarcinoma and squamous cell carcinoma in Iranian subjects.

  2009cites this paper
• Transitions at CpG Dinucleotides, Geographic Clustering of TP53 Mutations and Food Availability Patterns in Colorectal Cancer

  2009cites this paper
• puBlICatIons du personnel du CIrC 2008-2009

  2009cites this paper
• TP 53 Mutations in Human Cancers : Origins , Consequences , and Clinical Use

  2009cites this paper
• Neoplastic precursor lesions of the upper gastrointestinal tract

  2008cites this paper
• Does previous fundoplication alter the surgical approach to esophageal adenocarcinoma?

  2008cites this paper